I te ao hauora me te oranga tinana e tipu haere ana, kua rongonui te oleoylethanolamide (OEA) hei tāpiringa e mōhiotia ana mō ōna painga pea ki te whakahaere taumaha, te whakahaere hiahia kai, me te hauora pākia whānui. Kua piki ake te hiahia mō ngā hua paura oleoylethanolamide kounga teitei i te mea kua piki haere te mōhio o te tangata ki ōna painga. Heoi, he mahi uaua te kimi i te OEA kounga teitei nā te maha o ngā kōwhiringa e wātea ana.
Mā te mōhio ki ngā mea hei tirotiro me te wāhi hei hokohoko, ka taea e koe te whakatau whai whakaaro e hangai ana ki ō whāinga hauora. I te wā e whiriwhiri ana i te oleoylethanolamide, me aro tonu ki te parakore, te kounga me te māramatanga. Mā tēnei anake ka taea e koe te whiriwhiri i te paura oleoylethanolamide e tutuki ai ō hiahia.
Oleoylethanolamide (OEA),Ko te oleoylethanolamide, he ngako tūturu e hangaia ana i roto i te tinana, i roto i te whekau iti te nuinga. I ahu mai i te tauhohenga whākōkī o te waikawa oleic (he waikawa ngako monounsaturated e kitea ana i roto i ngā momo ngako kai) me te ethanolamine, he matū amide tuarua i hangaia mai i te waikawa oleic lipophilic me te ethanolamine hydrophilic.
He ngota ngako tūturu anō hoki te OEA i roto i ētahi atu kiko kararehe me ngā tipu. He whānuitia te kitea i roto i ngā kiko kararehe me ngā tipu pērā i te paura koko, te pīni soya, me ngā nati, engari he tino iti te nui o tōna ihirangi. Mēnā ka huri te taiao o waho, ka whakaohokia rānei te kai, ka nui ake te nui o te whakaputanga o tēnei matū i roto i ngā kiko pūtau o te tinana, nō reira ka taea hoki te whakamahi i te OEA hei tāpiringa kai.
He ngota amphiphilic te OEA e whakamahia ana i roto i te umanga matū hei surfactant me te hopi horoi. Heoi, i kitea e ētahi atu rangahau ka taea e te OEA te mahi hei ngota tohu lipid i roto i te tuaka puku-roro, ā, ka whakaatu i te raupapa o ngā mahi koiora i roto i te tinana, tae atu ki: te whakahaere i te hiahia kai, te whakapai ake i te pākia o te lipid, te whakarei ake i te mahara me te hinengaro me ētahi atu mahi. I roto i ēnei, ko ngā mahi a te OEA ki te whakahaere i te hiahia kai me te whakapai ake i te pākia o te lipid te mea i aro nuitia.
Oleoylethanolamide (OEA) He ngota tohu lipid taketake tēnei, ā, nō te akomanga ethanolamine o ngā matū. He mahi nui tāna i roto i te tinana mā te whakahaere i ngā tukanga pēnei i te hiahia kai, te pākia o te pūngao me te waikura o te waikawa ngako. Ko te OEA te mea nui ka hangaia i roto i te whekau iti, ā, ka pā ki te pūnaha io me ngā tukanga pākia mā te herea ki ngā kaiwhakawhiwhi motuhake.
He maha ngā tikanga mahi a te oleylethanolamide:
●Te whakahohenga o te PPAR-α: Ka herea e te OEA te PPAR-α, ā, ka whakahohehia e ia, he kaiwhakawhiwhi karihi e uru ana ki te pākia o te ngako, ka āwhina i te whakaiti i te kai e kainga ana me te whakanui ake i te whakapaunga pūngao.
●Whakaoho i te waikura ngako: Mā te whakahohe i te PPAR-α, ka taea e te OEA te whakarei ake i te pirau o ngā waikawa ngako i roto i te ate me te whakatairanga i te whakamahinga pūngao.
●Te whakahaere i te tuaka puku-roro: Ka pā te OEA ki ngā tohu makona mā te pā ki te io vagus, e kawe ana i ngā karere i waenga i te puku me te roro.
Ko te ECS (Pūnaha Endocannabinoid) he pūnaha tohu pūtau matatini e uru ana ngā endocannabinoids (pērā i ngā cannabinoids), ō rātou kaiwhakawhiwhi (CB1 me CB2), me ngā whākōkī hanga me te whakakorenga e pā ana. He mahi nui tā te ECS ki te whakahaere i ngā momo tukanga ā-tinana, tae atu ki te hiahia kai, te kite mamae, te wairua, te mahara, me ngā urupare ārai mate.
Ko te tikanga e pā ai te ECS ki ngā mahi ā-tinana:
Te whakahaere i te whanaketanga o ngā pūtau io me te kirihou o te hononga io: He mahi nui tā te ECS i roto i te tipu me te whanaketanga o ngā pūtau io, tae atu ki ngā tukanga pēnei i te neurogenesis, te hanganga glia, te hekenga o ngā pūtau io, te synaptogenesis, me te tapahi hononga io. He mahi nui tā te CB1R me te AEA i te wā o te whanaketanga o te tangata, ā, e hono ana ki te rerekētanga o ngā pūtau me te toronga o te axonal i roto i te pūnaha io matua.
Ka whakatikatika i te mamae me te utu: Ka whakatikatika ngā cannabinoids i te mamae mā te mahi ki ngā whāinga maha, ā, kua whakaatuhia he whakaora i ngā momo mamae maha. He mea nui anō hoki te ECS ki ngā pānga utu o ngā matū whakawara, e awe ana i te hiahia me te whanonga hoki anō mō ngā momo matū whakawara.
Whakahaere i te mahi a te kare ā-roto me te mahara: Kei roto te ECS i te whakahaere i te manukanuka, ā, ka pā ki ngā tukanga ako, pupuri, maumahara me te mōhio ki ngā momo mahara. He mahi tā te CB1R i roto i te mahi a ngā wāhi maha o te roro, ā, he pānga whakahaere pea ki te kare ā-roto me te mahara.
Whakahaere i te pūnaha ārai mate me ētahi atu mahi: Kei roto i ngā pūtau ārai mate te ECS, ā, ka taea e ia te awe i tā rātou mahi. Ka taea e te AEA te aukati i te tukunga o ngā cytokine mumura me te whakahaere i te mahi ārai mate. Hei tāpiri, kei te whai wāhi hoki te ECS ki te whakahaere i te hiahia kai, te whanonga kai, me ngā mahi ā-tinana o ngā pūnaha okana maha.
Ko te whanaungatanga i waenga i te oleoylethanolamine me te ECS e whakaatuhia ana i roto i ngā āhuatanga e whai ake nei:
Ngā Taunekeneke: Ka pā te OEA ki te hiahia me te taurite pūngao mā te taunekeneke ki ngā kaiwhakawhiwhi i roto i te ECS. E whakaarohia ana ka pehi te OEA i te hiahia me te whakatairanga i te waikura o ngā waikawa ngako.
Tikanga whakahaere: Ka pā pea te OEA ki te mahi a te ECS mā te whakahaere i te hanganga me te whakahekenga o ngā endocannabinoids, ā, ka whai wāhi nui ki te pākia o te pūngao me te whakahaere i te hiahia.
Te tūranga pea: Nā te mea he tūranga kei roto i te whakahaere i te pākia o te tinana me te hiahia kai, kei te tūhuratia e ngā kairangahau te tūranga pea kei roto i te momonatanga, te mate pākia o te tinana, me ētahi atu mate e pā ana.
I te nuinga, ko te taunekeneke i waenga i te oleoylethanolamine me te pūnaha endocannabinoid he wāhanga rangahau hohe, ā, ka taea te whakarato i ngā māramatanga hou ki te mārama me te rongoā i ngā mate e pā ana ki te pākia o te tinana.
1. Whakahaerehia te hiahia kai me te whakaiti i te taumaha
He mea nui te OEA hei aukati i te kai e kainga ana, ā, ko tana mahi matua he āwhina i te whakaiti i te momona. Mā te werohanga OEA ki roto i te puku ka taea te whakaiti i te kai e kainga ana me te whakanui i te taumaha o ngā kiore. Ka taea hoki e te hoatutanga ā-waha o te OEA te whakaputa i ngā pānga ōrite, engari kāore te werohanga OEA ki roto i te roro e pā ki tēnei. Kāore e pā ki te kai a ngā kiore. Ko te pānga matua o te OEA ki te whakaheke taumaha ko te whakaputa i te mākona, ā, ka whakahaere i te kai nui rawa. Mā te tāpiri i tētahi kukū o te OEA ki te kai a ngā kiore noa, momona rānei ka taea te whakaiti i te hiahia me te taumaha o ngā kiore.
Ehara i te mea ka aukati noa te OEA i te mimiti ngako o te puku, engari ka tere ake hoki te waikura beta o ngā waikawa ngako mā te whakatairanga i te waikura o ngā triglycerides i roto i ngā kiko taha (ate me te ngako), ā, ka mutu ka whakaitihia te kohikohinga ngako me te whakatutuki i te whakahaere taumaha.
2. Whakaiti i ngā ngako toto me te ātete i te atherosclerosis
Ko te kaiwhakawhiwhi-α e whakahohehia ana e te peroxisome proliferator (PPAR-α) he momo kaiwhakawhiwhi e pā tata ana ki ngā mahi pākia o te tinana. Ka whai wāhi te PPAR-α ki te pākia o te ngako mā te herea ki te huānga urupare peroxisome proliferator. Ko te kawe pākia, te whakahaere ārai mate, te ārai mumura, te ārai tipu me ētahi atu tukanga e pā ana ka whai wāhi anō ki te whakahaere i ngā ngako toto me te ārai i te atherosclerosis.
He rite te OEA ki te endocannabinoid e puta ana ina whakaohokia ngā kiko o te tinana. Kua whakaatuhia e ngā rangahau ka whakahohe te OEA i te PPAR-M, ka whakaiti i te tukunga o te endothelin-1, ka aukati i te vasoconstriction me te tipu o ngā pūtau uaua maeneene, ka whakatairanga i te vasodilation, ā, i te wa ano ka whakanui ake i te hanganga o te endothelial nitric oxide synthase me te whakaoho i te hanga o te nitric oxide synthase. hauota, nā reira ka whakaitihia te hanga o ngā ngota piri pūtau vascular, ka tutuki ngā pānga anti-inflammatory, me te whakaatu i ngā pānga o te whakaheke i ngā lipids toto me te anti-atherosclerosis.
3. Whakahaerehia te bulimia
Ko te mate kai nui (BED) te mate kai tino noa, e tohuhia ana e te kai nui rawa, kāore e taea te whakahaere, me te kai nui, me te ngaronga o te mana whakahaere, te whakama, te hara, te whakarihariha, me te manukanuka.
Ahakoa kāore anō kia tino whakatauhia ngā āhuatanga e hua ai te kai nui, kei reira ngā taunakitanga e kī ana ko te kai nui me te ahotea o te ao he mea noa hei whakaoho i te kai nui. Kua whakaatuhia e ētahi atu rangahau ko ngā tikanga koiora o te kai nui e arotahi ana ki te whakahohenga o te pūnaha dopamine limbic (DA) me te serotonin roro (5-HT) me te norepinephrine (NA).
Ko te Oleylethanolamide (OEA) he matūriki ngako e puta noa ana i te ao, he mahi nui tana ki te whakahaere i te hiahia kai, te whakahaere i te pūngao, me te whakahaere taumaha. Hei kaiwhakahaere tinana nui, ka taunekeneke te OEA me te kaiwhakawhiwhi α (PPAR-α) e whakahohehia ana e te peroxisome proliferator hei whakatairanga i te makona me te whakaoho i te waikura ngako. Kei te tūhuratia e ngā kairangahau te kaha rongoā o te OEA, ā, ka hua ake te whanaketanga o ngā tāpiringa oleoylethanolamide i hangaia hei tautoko i ēnei mahi.
I mua i te hokoOleylethanolamide (OEA) paura, whakaarohia ngā āhuatanga e whai ake nei:
1. Mārama ki te OEA
He aha tēnei: Ko te OEA he ethanolamide waikawa ngako e whai wāhi ana ki te whakahaere i te hiahia kai, te pākia o te tinana, me te homeostasis pūngao. Tērā pea ka āwhina i te whakahaere taumaha, te whakapai ake i te pākia o te ngako, me te whakanui ake i te whakapaunga pūngao.
2. Te Kounga me te Parakore
Puna: Hokona mai i ngā kaiwhakarato rongonui e tuku ana i ngā whakamātautau tuatoru mō te parakore me te kounga.
Tiwhikete Tātari (CoA): Mā te Tiwhikete Tātari (CoA) o tētahi hua e whakaū ana i tōna hanganga me te kore o ngā poke.
3. Te horopeta me te whakamahinga
Inenga kua tūtohutia: Rangahauhia te inenga kua tūtohutia, ka kōrero ki tētahi tohunga hauora mō ngā taunakitanga whaiaro.
Ngā Āhua Ka taea te Kai: He maha ngā āhua o te OEA (paura, kāpūru). Kōwhiria he hua e rite ana ki tō momo noho.
4. Ngā pānga taha pea
Ngā Pānga Taha Noa: Ahakoa e kiia ana he haumaru te nuinga, ka pāngia pea ētahi kaiwhakamahi e te mamae o te puku, e ētahi atu pānga taha iti rānei.
Me kōrero ki tō tākuta: Mena kei a koe tētahi mate hauora o mua, kei te tango rongoā rānei koe, me kōrero ki tō kaiwhakarato hauora i mua i te whakamahinga.
5. Tūnga ture
Ngā Ture: Tirohia te tūnga ture o te OEA i tō whenua, nā te mea ka rerekē pea ngā ture.
6. Te rokiroki me te roa o te wā e mau ana
Ngā Tikanga Rokiroki: Kia mārama koe ki te penapena tika i te paura kia mau tonu ai tōna whai huatanga.
Rā paunga: Tirohia te rā paunga kia mōhio ai koe kei te hoko koe i tētahi hua hou.
7. Te utu me te uara
Whakataurite Utu: Whakatauritea ngā utu mai i ngā kaiwhakarato rerekē, engari kia tūpato ki ngā utu tino iti e tohu ana pea i te kounga iti.
Hokona nui: Ki te whakaaro koe ki te whakamahi mō te wā roa, whakaarohia te hoko nui nā te mea ka taea te penapena utu.
8. Whakakotahitia ki ētahi atu tāpiringa
Ngā Pānga Whakakotahi: Rangahauhia te taunekeneke a te OEA me ētahi atu tāpiringa, ngā huringa kai rānei ka whakaarohia e koe.
Mā te whai whakaaro ki ēnei āhuatanga, ka taea e koe te whakatau whai whakaaro ake i te wā e hoko ana koe i te paura oleoylethanolamide. Me aro tonu ki te haumaru me te kounga i te wā e whiriwhiri ana i tētahi tāpiringa.
Kua ngaro ngā rā i kore ai koe i te mōhio ki hea e hoko ai i te paura oleylethanolamine. I ēnei rā, he maha ngā wāhi ka taea e koe te hoko i te paura konupora acetyl taurate. Nā te ipurangi, ka taea e koe te hoko i tetahi mea me te kore e wehe atu i tō kāinga. Ehara i te mea ka māmā ake tō mahi mā te ipurangi, engari ka watea ake hoki tō wheako hokohoko. Kei a koe anō te whai wāhi ki te pānui atu mō tēnei oleoylethanolamine whakamiharo i mua i tō whakatau ki te hoko.
He kaihanga kua rēhitatia ki te FDA a Suzhou Myland Pharm & Nutrition Inc. e whakarato ana i te paura Oleoylethanolamide (OEA) kounga teitei, parakore hoki.
I Suzhou Myland Pharm, e whakapau kaha ana mātou ki te whakarato i ngā hua kounga teitei rawa atu i ngā utu pai rawa atu. Kua whakamatautauria te paura Oleoylethanolamide (OEA) kia tino parakore, kia kaha hoki, kia whiwhi ai koe i tētahi tāpiringa kounga teitei ka taea e koe te whakawhirinaki. Ahakoa e hiahia ana koe ki te tautoko i te hauora pūtau, ki te whakapakari i tō pūnaha ārai mate, ki te whakarei ake rānei i te hauora whānui, ko tā mātou paura Oleoylethanolamide (OEA) te whiringa tino pai.
Me te 30 tau o te wheako, ā, e ārahihia ana e te hangarau matatau me ngā rautaki R&D kua tino arotauhia, kua whakawhanakehia e Suzhou Myland Pharm he whānuitanga o ngā hua whakataetae, ā, kua riro hei kamupene auaha mō ngā tāpiringa pūtaiao koiora, te hanga ritenga me ngā ratonga hanga.
Hei tāpiritanga, he kaihanga kua rēhitatia ki te FDA a Suzhou Myland Pharm. He hou, he maha ngā mahi a ngā rauemi R&D a te kamupene, ngā whare whakaputa, me ngā taputapu tātari, ā, ka taea te whakaputa matū mai i te mirikaramu ki te tana i te tauine, me te tutuki i ngā paerewa ISO 9001 me ngā whakaritenga whakaputa GMP.
P: He aha te Oleoylethanolamide (OEA) ā, he aha ōna painga?
A: Ko te Oleoylethanolamide (OEA) he ngako tūturu e whai wāhi ana ki te whakahaere i te hiahia kai, te pākia o te tinana, me te taurite o te pūngao. He maha ngā wā ka whakamahia hei tāpiringa kai hei whakahaere i te taumaha, hei whakatairanga i te makona, me te whakarei ake i te pākia o te ngako.
Q: Me pēhea taku whakatau i te kounga o te paura Oleoylethanolamide?
A: Hei whakatau i te kounga o te paura Oleoylethanolamide, rapua ngā hua e whakarato ana i te Tiwhikete Tātari (COA) mai i tētahi taiwhanga tuatoru. Hei tāpiri, tirohia ngā arotake a ngā kiritaki, te mārama o ngā kai, me te kore he poke me ngā whakakī i roto i te hua.
Q: He aha ngā mea me whakaaro ahau ina hoko ana i te paura Oleoylethanolamide?
A: I te hoko i te paura Oleoylethanolamide, whakaarohia ngā āhuatanga pēnei i te pūtake o te hua, te kukū o te OEA, te aroaro o ngā tāpiringa, te ingoa o te kaihanga, me ngā urupare a te kiritaki. He mea nui hoki kia tirohia ngā tohutohu rokiroki me te whakahaere tika.
Whakakape: He kōrero whānui noa iho tēnei tuhinga, kaua e whakamāramatia he tohutohu hauora. Ko ētahi o ngā kōrero o te pou rangitaki i ahu mai i te Ipurangi, ehara i te mea ngaio. Ko tā tēnei paetukutuku anake he whakarōpū, he whakatakotoranga me te whakatika i ngā tuhinga. Ko te kaupapa o te kawe atu i ētahi atu kōrero, ehara i te mea e whakaae ana koe ki ōna tirohanga, e whakaū ana rānei i te pono o ōna ihirangi. Me kōrero tonu ki tētahi tohunga hauora i mua i te whakamahi i tētahi tāpiringa, i te hanga rānei i ngā huringa ki tō tikanga tiaki hauora.
Wā tuku: Hepetema-27-2024
